Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Eiki Kikuchi
Kinase Domain Activation of FGFR2 Yields High-Grade Lung Adenocarcinoma Sensitive to a Pan-FGFR Inhibitor in a Mouse Model of NSCLC
Cancer Research
Cancer Research
Oncology
A Clinical Analysis of 10 Cases With Oligometastases of Non-Small Cell Carcinoma
Japanese Journal of Lung Cancer
Oncology
Respiratory Medicine
Pulmonary
Related publications
Rogaratinib: A Potent and Selective Pan-FGFR Inhibitor With Broad Antitumor Activity in FGFR-overexpressing Preclinical Cancer Models
International Journal of Cancer
Cancer Research
Oncology
Activation of the Met Kinase Confers Acquired Drug Resistance in FGFR-targeted Lung Cancer Therapy
Oncogenesis
Cancer Research
Molecular Biology
Antitumor Effect of FGFR Inhibitors on a Novel Cholangiocarcinoma Patient Derived Xenograft Mouse Model Endogenously Expressing an FGFR2-CCDC6 Fusion Protein
Cancer Letters
Cancer Research
Oncology
P1.01-72 FIND Trial: A Phase II Study to Evaluate the Efficacy of the FGFR-Inhibitor Erdafitinib in FGFR-Mutated and -Translocated Squamous NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Targeting Hepatocarcinogenesis Model in C56BL6 Mice With Pan-Aurora Kinase Inhibitor Danusertib
Journal of Cancer
Oncology
Familial Scaphocephaly Syndrome Caused by a Novel Mutation in the FGFR2 Tyrosine Kinase Domain
Journal of Medical Genetics
Genetics
Effects of FGFR2 Kinase Activation Loop Dynamics on Catalytic Activity
PLoS Computational Biology
Molecular Neuroscience
Evolution
Ecology
Genetics
Behavior
Molecular Biology
Systematics
Simulation
Cellular
Computational Theory
Mathematics
Modeling
Development and Validation of a Model to Predict Tyrosine Kinase Inhibitor-Sensitive EGFR Mutations of Non-Small Cell Lung Cancer Based on Multi-Institutional Data
Thoracic Cancer
Medicine
Pulmonary
Respiratory Medicine
Oncology
MA27.07 Lung Adenocarcinoma Harboring BRAF G469V Mutation Is Uniquely Sensitive to EGFR Tyrosine Kinase Inhibitors
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary